Could PCSK9 Be Suppressed With Twice-Yearly Injection?

ACC Conference Reporter

AHA 2015 | ORLANDO, FL — A novel RNA interference drug targeted to PCSK9 given every 6 months could cut LDL on par with the monthly PCSK9 inhibitors, early phase research suggests. Read More >>>

Keywords: AHA Annual Scientific Sessions


< Back to Listings